Sep 2023 $6 M No. 6 $2 to $10 million 7
Third Eye Health, Inc.: Raise no. 6, Sep 2023 × Investors in this round 7 investors had bought by the notice of Sep 11, 2023: 7 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M of $6 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Dan Herbstman · Executive Officer, Director, Promoter Lucas Baran · Executive Officer Kirsten Morbeck · Director Leo Brubaker · Director Mary Kate Salley · Director Rachel Kern · Director Russell Hirsch · Director Steve Lefar · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Proceeds will be used for working capital, which may include normal compensation to executive officers.”Signed by Dan Herbstman, Ceo. Source: SEC Form D, newest notice filed Sep 11, 2023. Read the notice at the SEC .
equity SEC Jan 2022 $4 M No. 5 $2 to $10 million 25
Third Eye Health, Inc.: Raise no. 5, Jan 2022 × Investors in this round 25 investors had bought by the notice of Apr 25, 2022: 25 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $4 M offered; $0 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Dan Herbstman · Executive Officer, Director Steven Lefar · Executive Officer, Director, Promoter David Reis · Director Kristin Morbeck · Director Mary Kate Salley · Director Russell Hirsch · Director Yaakov Spinrad · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Proceeds will be used for working capital, which may include normal compensation to executive officers.”Signed by Steven Lefar, Chairman of the Board. Source: SEC Form D, newest notice filed Apr 25, 2022. Read the notice at the SEC .
debt, options SEC Oct 2020 $4 M No. 4 $2 to $10 million 12
Third Eye Health, Inc.: Raise no. 4, Oct 2020 × Investors in this round 12 investors had bought by the notice of Dec 3, 2020: 12 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $5 M offered; $0 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Dan Herbstman · Executive Officer, Director Mary Kate Salley · Executive Officer, Director, Promoter Amish Patel · Director David Reis · Director Russell Hirsch · Director Stefan Lefar · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Proceeds will be used for working capital, which may include normal compensation to executive officers.”Signed by Mary Kate Salley, Ceo. Source: SEC Form D, newest notice filed Dec 3, 2020. Read the notice at the SEC .
debt, options SEC Dec 2019 $6 M No. 3 $2 to $10 million 30
Third Eye Health, Inc.: Raise no. 3, Dec 2019 × Investors in this round 30 investors had bought by the notice of Dec 3, 2020: 30 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M of $6 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Mary Kate Salley · Executive Officer, Director, Promoter Dan Herbstman · Director David Reis · Director Russell Hirsch · Director Stefan Lefar · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Proceeds will be used for working capital, which may include normal compensation to executive officers.”Signed by Mary Kate Salley, Ceo. Source: SEC Form D, newest notice filed Dec 3, 2020. Read the notice at the SEC .
debt, options SEC Dec 2018 $7 M No. 2 $2 to $10 million 19
Third Eye Health, Inc.: Raise no. 2, Dec 2018 × Investors in this round 19 investors had bought by the notice of Jan 23, 2019: 19 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $7 M of $7 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Daniel Herbstman · Executive Officer, Director, Promoter Lucas Baran · Executive Officer, Director, Promoter Amish Patel · Director David Reis · Director Katy Fike · Director Russell Hirsch · Director Steven Lefar · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Proceeds will be used for working capital, which will include normal compensation to executive officers.”Signed by Daniel Herbstman, Chief Executive Officer. Source: SEC Form D, newest notice filed Jan 23, 2019. Read the notice at the SEC .
equity, options SEC Nov 2016 $1 M No. 1 Under $2 million 1
Third Eye Health, Inc.: Raise no. 1, Nov 2016 × Investors in this round 1 investor had bought by the notice of Nov 17, 2016: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $1 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Daniel Herbstman · Executive Officer, Director, Promoter Lucas Baran · Executive Officer, Director, Promoter Jamison Feramisco · Director Michael Sachs · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Proceeds will be used for working capital, which will include normal compensation to executive officers.”Signed by Daniel Herbstman, Chief Executive Officer. Source: SEC Form D, newest notice filed Nov 17, 2016. Read the notice at the SEC .
equity, options SEC